Biodexa Pharmaceuticals Plc financial data

Symbol
BDRX on Nasdaq
Location
Cardiff
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 11 Apr 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.69B shares +462%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 14.8M GBP +40.2%
Liabilities 6.46M GBP +10.1%